ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Through these mechanisms, adiponectin suppresses metabolic derangements that may result in type 2 diabetes (T2DM), obesity, atherosclerosis, non-alcoholic fatty liver disease, and metabolic syndrome.